A.
Specific Aims : The Administration Core will provide oversight and Administrative, Biostatistics and Clinical Research support for the projects and cores that comprise the Host Defense Regulation and Viral Oncogenesis Program. The goal of the Administration Core is to monitor the activities of the program components and facilitate communication and collaborations among the participants of this program project application.
The specific aims of the Administrative Core areas follow: 1) To provide administrative oversight and support for the projects and cores 2) To facilitate communication and collaboration among investigators by coordinating all program project meetings including Internal and External Advisory Boards meetings 3) To provide budgetary and fiscal management 4) To provide biostatistics support for design, implementation and interpretation studies proposed 5) To provide clinical research support for the clinical components of the program project

Public Health Relevance

(See Instructions): The Administration core will assist the POl projects with the experimental design and data analysis, data storage and clinical management needed to support the specific aims of the various projects. The benefit to overall public health is elucidation of mechanism of ATLL development and possible improved treatments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA128115-05
Application #
8546187
Study Section
Special Emphasis Panel (ZCA1-GRB-S)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
5
Fiscal Year
2013
Total Cost
$154,161
Indirect Cost
$50,498
Name
University of Miami School of Medicine
Department
Type
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Bayraktar, Ulas Darda; Diaz, Luis A; Ashlock, Brittany et al. (2014) Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas. Leuk Lymphoma 55:786-94
Charoenthongtrakul, Soratree; Gao, Linlin; Parvatiyar, Kislay et al. (2013) RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. PLoS One 8:e53717
Gao, Linlin; Harhaj, Edward William (2013) HSP90 protects the human T-cell leukemia virus type 1 (HTLV-1) tax oncoprotein from proteasomal degradation to support NF-*B activation and HTLV-1 replication. J Virol 87:13640-54
Lavorgna, Alfonso; Harhaj, Edward W (2013) Is there a role for ubiquitin or SUMO in human T-cell leukemia virus type 2 Tax-induced NF-*B activation? Future Virol 8:223-227
Shembade, Noula; Harhaj, Edward W (2012) Regulation of NF-?B signaling by the A20 deubiquitinase. Cell Mol Immunol 9:123-30
Harhaj, Edward W; Dixit, Vishva M (2012) Regulation of NF-*B by deubiquitinases. Immunol Rev 246:107-24
Lavorgna, Alfonso; Harhaj, Edward W (2012) EBV LMP1: New and shared pathways to NF-ýýB activation. Proc Natl Acad Sci U S A 109:2188-9
Ramos, Juan Carlos; Lossos, Izidore S (2011) Newly emerging therapies targeting viral-related lymphomas. Curr Oncol Rep 13:416-26
Charoenthongtrakul, Soratree; Zhou, Qinjie; Shembade, Noula et al. (2011) Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1. J Virol 85:6955-62
Harhaj, Edward W; Dixit, Vishva M (2011) Deubiquitinases in the regulation of NF-?B signaling. Cell Res 21:22-39

Showing the most recent 10 out of 15 publications